As a confirmation, a publication from 2021 has highlighted the fact that only MFS, and not BCR, was a strong surrogate marker of PC-specific mortality since the development of bone metastasis is linked to the castration-resistant state when ADT is initiated in these patients [12]. This evidence concerns the gene BCR and pachyonychia congenita.